Company & Sponsor Intelligence

Ohio State University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials10

Recruiting2

Completed6

Countries1

Therapeutic footprint

adhdalzheimersautismother_psychiatryparkinsonsptsdsleep_disorders

Indexed studies

NCT00773812Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders
autism · United StatesPHASE1

NCT00472511Study of Eyes and Attention Deficit (SEAD)
adhd · COMPLETED

NCT06326424Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department
alzheimers · United StatesRECRUITING

NCT05524753Active Ingredients & Efficacy of Aquatic Therapy for Autistic Children
autism · United StatesNA

NCT03751371Robotic Walking Device to Improve Mobility in Parkinson's Disease
parkinsons · United StatesNA

NCT05554094Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
ptsd · United StatesPHASE2

NCT03198156Transcranial Direct Current Stimulation Therapy for Central Hypersomnia Without Cataplexy
other_psychiatry · United StatesNA

NCT03879044Transcranial Direct Current Stimulation Therapy for Sleepiness Related to Shift Work Disorder (tDCS-SWORD)
sleep_disorders · United StatesNA

NCT01210534Physiological Brain Atlas Development
parkinsons · United StatesCOMPLETED

NCT06530680Upper Extremity Function Before and After Hippotherapy in Children With Autism Spectrum Disorder and/or Cerebral Palsy
autism · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →